Artiva Biotherapeutics (ARTV) Other Accumulated Expenses (2023 - 2025)
Historic Other Accumulated Expenses for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $895000.0.
- Artiva Biotherapeutics' Other Accumulated Expenses fell 5964.83% to $895000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $895000.0, marking a year-over-year decrease of 5964.83%. This contributed to the annual value of $1.5 million for FY2024, which is 4854.95% down from last year.
- According to the latest figures from Q3 2025, Artiva Biotherapeutics' Other Accumulated Expenses is $895000.0, which was down 5964.83% from $997000.0 recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Other Accumulated Expenses registered a high of $2.9 million during Q4 2023, and its lowest value of $895000.0 during Q3 2025.
- For the 3-year period, Artiva Biotherapeutics' Other Accumulated Expenses averaged around $1.6 million, with its median value being $1.2 million (2024).
- In the last 5 years, Artiva Biotherapeutics' Other Accumulated Expenses crashed by 4854.95% in 2024 and then crashed by 5964.83% in 2025.
- Over the past 3 years, Artiva Biotherapeutics' Other Accumulated Expenses (Quarter) stood at $2.9 million in 2023, then plummeted by 48.55% to $1.5 million in 2024, then tumbled by 39.2% to $895000.0 in 2025.
- Its Other Accumulated Expenses was $895000.0 in Q3 2025, compared to $997000.0 in Q2 2025 and $1.0 million in Q1 2025.